Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cardinal Health ( (CAH) ) has shared an announcement.
On August 27, 2025, Cardinal Health completed a public offering of $1 billion in notes, with proceeds intended to fund part of its proposed acquisition of Solaris Health. If the acquisition is not completed by August 12, 2026, or if Cardinal Health decides not to pursue it, the company will be required to redeem the notes at a premium.
The most recent analyst rating on (CAH) stock is a Hold with a $155.00 price target. To see the full list of analyst forecasts on Cardinal Health stock, see the CAH Stock Forecast page.
Spark’s Take on CAH Stock
According to Spark, TipRanks’ AI Analyst, CAH is a Neutral.
Cardinal Health’s overall stock score reflects a mix of strong revenue growth and strategic initiatives, balanced by significant financial challenges and a bearish technical outlook. The company’s proactive approach to acquisitions and capital management is promising, but high leverage and valuation concerns weigh on the score.
To see Spark’s full report on CAH stock, click here.
More about Cardinal Health
Cardinal Health is a healthcare services and products company that provides pharmaceuticals, medical products, and services to healthcare providers and manufacturers. The company focuses on improving the cost-effectiveness of healthcare delivery.
Average Trading Volume: 2,261,643
Technical Sentiment Signal: Buy
Current Market Cap: $35.22B
For an in-depth examination of CAH stock, go to TipRanks’ Overview page.